nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Gonadorelin—Degarelix—prostate cancer	0.427	0.601	CrCrCtD
Terlipressin—Gonadorelin—Goserelin—prostate cancer	0.283	0.398	CrCrCtD
Terlipressin—AVPR2—urine—prostate cancer	0.0181	0.803	CbGeAlD
Terlipressin—AVPR2—renal system—prostate cancer	0.00442	0.197	CbGeAlD
Terlipressin—Hypertension—Bicalutamide—prostate cancer	0.000463	0.00299	CcSEcCtD
Terlipressin—Hyponatraemia—Mitoxantrone—prostate cancer	0.000459	0.00296	CcSEcCtD
Terlipressin—Chest pain—Bicalutamide—prostate cancer	0.000457	0.00295	CcSEcCtD
Terlipressin—Dyspnoea—Cabazitaxel—prostate cancer	0.000455	0.00293	CcSEcCtD
Terlipressin—Diarrhoea—Abiraterone—prostate cancer	0.000454	0.00293	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Bicalutamide—prostate cancer	0.000453	0.00293	CcSEcCtD
Terlipressin—Malnutrition—Ethinyl Estradiol—prostate cancer	0.000453	0.00292	CcSEcCtD
Terlipressin—Abdominal pain—Estradiol valerate/Dienogest—prostate cancer	0.00045	0.00291	CcSEcCtD
Terlipressin—Respiratory failure—Docetaxel—prostate cancer	0.000444	0.00286	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.00044	0.00284	CcSEcCtD
Terlipressin—Vomiting—Estramustine—prostate cancer	0.000434	0.0028	CcSEcCtD
Terlipressin—Nervous system disorder—Bicalutamide—prostate cancer	0.000429	0.00277	CcSEcCtD
Terlipressin—Abdominal pain—Degarelix—prostate cancer	0.000428	0.00276	CcSEcCtD
Terlipressin—Headache—Estramustine—prostate cancer	0.000428	0.00276	CcSEcCtD
Terlipressin—Skin disorder—Bicalutamide—prostate cancer	0.000425	0.00274	CcSEcCtD
Terlipressin—Vomiting—Abiraterone—prostate cancer	0.000422	0.00272	CcSEcCtD
Terlipressin—Skin exfoliation—Docetaxel—prostate cancer	0.000416	0.00268	CcSEcCtD
Terlipressin—Vomiting—Estrone—prostate cancer	0.000415	0.00268	CcSEcCtD
Terlipressin—Diarrhoea—Nilutamide—prostate cancer	0.000415	0.00268	CcSEcCtD
Terlipressin—Diarrhoea—Flutamide—prostate cancer	0.000413	0.00266	CcSEcCtD
Terlipressin—Headache—Estrone—prostate cancer	0.000409	0.00264	CcSEcCtD
Terlipressin—Nausea—Estramustine—prostate cancer	0.000406	0.00262	CcSEcCtD
Terlipressin—Abdominal pain—Cabazitaxel—prostate cancer	0.000403	0.0026	CcSEcCtD
Terlipressin—Skin exfoliation—Capecitabine—prostate cancer	0.000403	0.0026	CcSEcCtD
Terlipressin—Cardiac disorder—Goserelin—prostate cancer	0.000398	0.00257	CcSEcCtD
Terlipressin—Cardiac disorder—Conjugated Estrogens—prostate cancer	0.000394	0.00254	CcSEcCtD
Terlipressin—Dyspnoea—Bicalutamide—prostate cancer	0.00039	0.00252	CcSEcCtD
Terlipressin—Cardiac failure—Etoposide—prostate cancer	0.00039	0.00252	CcSEcCtD
Terlipressin—Angiopathy—Goserelin—prostate cancer	0.000389	0.00251	CcSEcCtD
Terlipressin—Pulmonary oedema—Docetaxel—prostate cancer	0.000388	0.0025	CcSEcCtD
Terlipressin—Nausea—Estrone—prostate cancer	0.000388	0.0025	CcSEcCtD
Terlipressin—Vomiting—Nilutamide—prostate cancer	0.000385	0.00249	CcSEcCtD
Terlipressin—Angiopathy—Conjugated Estrogens—prostate cancer	0.000385	0.00249	CcSEcCtD
Terlipressin—Vomiting—Flutamide—prostate cancer	0.000384	0.00248	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—prostate cancer	0.000383	0.00247	CcSEcCtD
Terlipressin—Headache—Nilutamide—prostate cancer	0.00038	0.00245	CcSEcCtD
Terlipressin—Headache—Flutamide—prostate cancer	0.000378	0.00244	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.000378	0.00244	CcSEcCtD
Terlipressin—Acute coronary syndrome—Estradiol—prostate cancer	0.000373	0.00241	CcSEcCtD
Terlipressin—Malnutrition—Goserelin—prostate cancer	0.000373	0.00241	CcSEcCtD
Terlipressin—Myocardial infarction—Estradiol—prostate cancer	0.000371	0.00239	CcSEcCtD
Terlipressin—Diarrhoea—Degarelix—prostate cancer	0.000371	0.00239	CcSEcCtD
Terlipressin—Malnutrition—Conjugated Estrogens—prostate cancer	0.00037	0.00238	CcSEcCtD
Terlipressin—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000363	0.00234	CcSEcCtD
Terlipressin—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000362	0.00234	CcSEcCtD
Terlipressin—Nausea—Nilutamide—prostate cancer	0.00036	0.00232	CcSEcCtD
Terlipressin—Skin disorder—Ethinyl Estradiol—prostate cancer	0.000359	0.00232	CcSEcCtD
Terlipressin—Skin exfoliation—Prednisone—prostate cancer	0.000359	0.00231	CcSEcCtD
Terlipressin—Nausea—Flutamide—prostate cancer	0.000359	0.00231	CcSEcCtD
Terlipressin—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000357	0.0023	CcSEcCtD
Terlipressin—Diarrhoea—Cabazitaxel—prostate cancer	0.000349	0.00225	CcSEcCtD
Terlipressin—Acute coronary syndrome—Mitoxantrone—prostate cancer	0.000348	0.00224	CcSEcCtD
Terlipressin—Abdominal pain—Bicalutamide—prostate cancer	0.000346	0.00223	CcSEcCtD
Terlipressin—Myocardial infarction—Mitoxantrone—prostate cancer	0.000346	0.00223	CcSEcCtD
Terlipressin—Vomiting—Degarelix—prostate cancer	0.000344	0.00222	CcSEcCtD
Terlipressin—Headache—Degarelix—prostate cancer	0.000339	0.00219	CcSEcCtD
Terlipressin—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000338	0.00218	CcSEcCtD
Terlipressin—Hot flush—Docetaxel—prostate cancer	0.000338	0.00218	CcSEcCtD
Terlipressin—Octreotide—MPO—prostate cancer	0.000337	0.748	CrCbGaD
Terlipressin—Menopausal symptoms—Docetaxel—prostate cancer	0.000335	0.00216	CcSEcCtD
Terlipressin—Pulmonary oedema—Prednisone—prostate cancer	0.000334	0.00216	CcSEcCtD
Terlipressin—Atrial fibrillation—Docetaxel—prostate cancer	0.000334	0.00215	CcSEcCtD
Terlipressin—Hot flush—Capecitabine—prostate cancer	0.000327	0.00211	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Epirubicin—prostate cancer	0.000325	0.0021	CcSEcCtD
Terlipressin—Menopausal symptoms—Capecitabine—prostate cancer	0.000325	0.00209	CcSEcCtD
Terlipressin—Vomiting—Cabazitaxel—prostate cancer	0.000324	0.00209	CcSEcCtD
Terlipressin—Cardiac failure—Docetaxel—prostate cancer	0.000324	0.00209	CcSEcCtD
Terlipressin—Atrial fibrillation—Capecitabine—prostate cancer	0.000323	0.00209	CcSEcCtD
Terlipressin—Bradycardia—Mitoxantrone—prostate cancer	0.000322	0.00208	CcSEcCtD
Terlipressin—Hypertension—Goserelin—prostate cancer	0.000322	0.00208	CcSEcCtD
Terlipressin—Nausea—Degarelix—prostate cancer	0.000322	0.00208	CcSEcCtD
Terlipressin—Headache—Cabazitaxel—prostate cancer	0.00032	0.00206	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000319	0.00206	CcSEcCtD
Terlipressin—Chest pain—Goserelin—prostate cancer	0.000318	0.00205	CcSEcCtD
Terlipressin—Hyponatraemia—Docetaxel—prostate cancer	0.000318	0.00205	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.000315	0.00204	CcSEcCtD
Terlipressin—Cardiac disorder—Estradiol—prostate cancer	0.000315	0.00203	CcSEcCtD
Terlipressin—Chest pain—Conjugated Estrogens—prostate cancer	0.000315	0.00203	CcSEcCtD
Terlipressin—Cardiac failure—Capecitabine—prostate cancer	0.000314	0.00202	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.000312	0.00202	CcSEcCtD
Terlipressin—Angiopathy—Estradiol—prostate cancer	0.000308	0.00199	CcSEcCtD
Terlipressin—Hyponatraemia—Capecitabine—prostate cancer	0.000307	0.00198	CcSEcCtD
Terlipressin—Nausea—Cabazitaxel—prostate cancer	0.000303	0.00196	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Doxorubicin—prostate cancer	0.000301	0.00194	CcSEcCtD
Terlipressin—Diarrhoea—Bicalutamide—prostate cancer	0.000299	0.00193	CcSEcCtD
Terlipressin—Nervous system disorder—Goserelin—prostate cancer	0.000299	0.00193	CcSEcCtD
Terlipressin—Tachycardia—Goserelin—prostate cancer	0.000297	0.00192	CcSEcCtD
Terlipressin—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000296	0.00191	CcSEcCtD
Terlipressin—Malnutrition—Estradiol—prostate cancer	0.000296	0.00191	CcSEcCtD
Terlipressin—Skin disorder—Goserelin—prostate cancer	0.000296	0.00191	CcSEcCtD
Terlipressin—Tachycardia—Conjugated Estrogens—prostate cancer	0.000294	0.0019	CcSEcCtD
Terlipressin—Skin disorder—Conjugated Estrogens—prostate cancer	0.000293	0.00189	CcSEcCtD
Terlipressin—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000292	0.00189	CcSEcCtD
Terlipressin—Acute coronary syndrome—Etoposide—prostate cancer	0.000289	0.00187	CcSEcCtD
Terlipressin—Myocardial infarction—Etoposide—prostate cancer	0.000287	0.00186	CcSEcCtD
Terlipressin—Skin exfoliation—Epirubicin—prostate cancer	0.000281	0.00181	CcSEcCtD
Terlipressin—Cardiac failure—Prednisone—prostate cancer	0.00028	0.0018	CcSEcCtD
Terlipressin—Vomiting—Bicalutamide—prostate cancer	0.000278	0.0018	CcSEcCtD
Terlipressin—Headache—Bicalutamide—prostate cancer	0.000274	0.00177	CcSEcCtD
Terlipressin—Dyspnoea—Goserelin—prostate cancer	0.000271	0.00175	CcSEcCtD
Terlipressin—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000269	0.00173	CcSEcCtD
Terlipressin—Pulmonary oedema—Epirubicin—prostate cancer	0.000262	0.00169	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.00026	0.00168	CcSEcCtD
Terlipressin—Nausea—Bicalutamide—prostate cancer	0.00026	0.00168	CcSEcCtD
Terlipressin—Skin exfoliation—Doxorubicin—prostate cancer	0.00026	0.00168	CcSEcCtD
Terlipressin—Hypertension—Estradiol—prostate cancer	0.000255	0.00165	CcSEcCtD
Terlipressin—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000253	0.00163	CcSEcCtD
Terlipressin—Chest pain—Estradiol—prostate cancer	0.000252	0.00162	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.00025	0.00161	CcSEcCtD
Terlipressin—Cardiac disorder—Etoposide—prostate cancer	0.000244	0.00158	CcSEcCtD
Terlipressin—Pulmonary oedema—Doxorubicin—prostate cancer	0.000242	0.00156	CcSEcCtD
Terlipressin—Abdominal pain—Goserelin—prostate cancer	0.000241	0.00155	CcSEcCtD
Terlipressin—Acute coronary syndrome—Docetaxel—prostate cancer	0.00024	0.00155	CcSEcCtD
Terlipressin—Myocardial infarction—Docetaxel—prostate cancer	0.000239	0.00154	CcSEcCtD
Terlipressin—Angiopathy—Etoposide—prostate cancer	0.000239	0.00154	CcSEcCtD
Terlipressin—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000238	0.00154	CcSEcCtD
Terlipressin—Hypertension—Mitoxantrone—prostate cancer	0.000238	0.00154	CcSEcCtD
Terlipressin—Nervous system disorder—Estradiol—prostate cancer	0.000237	0.00153	CcSEcCtD
Terlipressin—Tachycardia—Estradiol—prostate cancer	0.000236	0.00152	CcSEcCtD
Terlipressin—Vomiting—Ethinyl Estradiol—prostate cancer	0.000235	0.00152	CcSEcCtD
Terlipressin—Chest pain—Mitoxantrone—prostate cancer	0.000235	0.00151	CcSEcCtD
Terlipressin—Skin disorder—Estradiol—prostate cancer	0.000234	0.00151	CcSEcCtD
Terlipressin—Acute coronary syndrome—Capecitabine—prostate cancer	0.000233	0.0015	CcSEcCtD
Terlipressin—Headache—Ethinyl Estradiol—prostate cancer	0.000232	0.0015	CcSEcCtD
Terlipressin—Myocardial infarction—Capecitabine—prostate cancer	0.000231	0.00149	CcSEcCtD
Terlipressin—Hot flush—Epirubicin—prostate cancer	0.000228	0.00147	CcSEcCtD
Terlipressin—Menopausal symptoms—Epirubicin—prostate cancer	0.000226	0.00146	CcSEcCtD
Terlipressin—Nausea—Ethinyl Estradiol—prostate cancer	0.00022	0.00142	CcSEcCtD
Terlipressin—Tachycardia—Mitoxantrone—prostate cancer	0.000219	0.00142	CcSEcCtD
Terlipressin—Cardiac failure—Epirubicin—prostate cancer	0.000219	0.00141	CcSEcCtD
Terlipressin—Skin disorder—Mitoxantrone—prostate cancer	0.000218	0.00141	CcSEcCtD
Terlipressin—Bradycardia—Capecitabine—prostate cancer	0.000216	0.00139	CcSEcCtD
Terlipressin—Dyspnoea—Estradiol—prostate cancer	0.000215	0.00139	CcSEcCtD
Terlipressin—Hyponatraemia—Epirubicin—prostate cancer	0.000214	0.00138	CcSEcCtD
Terlipressin—Hot flush—Doxorubicin—prostate cancer	0.000211	0.00136	CcSEcCtD
Terlipressin—Menopausal symptoms—Doxorubicin—prostate cancer	0.000209	0.00135	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Estradiol—prostate cancer	0.000208	0.00134	CcSEcCtD
Terlipressin—Diarrhoea—Goserelin—prostate cancer	0.000208	0.00134	CcSEcCtD
Terlipressin—Acute coronary syndrome—Prednisone—prostate cancer	0.000207	0.00134	CcSEcCtD
Terlipressin—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000206	0.00133	CcSEcCtD
Terlipressin—Myocardial infarction—Prednisone—prostate cancer	0.000206	0.00133	CcSEcCtD
Terlipressin—Cardiac disorder—Docetaxel—prostate cancer	0.000203	0.00131	CcSEcCtD
Terlipressin—Cardiac failure—Doxorubicin—prostate cancer	0.000202	0.00131	CcSEcCtD
Terlipressin—Dyspnoea—Mitoxantrone—prostate cancer	0.0002	0.00129	CcSEcCtD
Terlipressin—Angiopathy—Docetaxel—prostate cancer	0.000199	0.00128	CcSEcCtD
Terlipressin—Hyponatraemia—Doxorubicin—prostate cancer	0.000198	0.00128	CcSEcCtD
Terlipressin—Hypertension—Etoposide—prostate cancer	0.000198	0.00128	CcSEcCtD
Terlipressin—Cardiac disorder—Capecitabine—prostate cancer	0.000197	0.00127	CcSEcCtD
Terlipressin—Chest pain—Etoposide—prostate cancer	0.000195	0.00126	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000194	0.00125	CcSEcCtD
Terlipressin—Vomiting—Goserelin—prostate cancer	0.000194	0.00125	CcSEcCtD
Terlipressin—Angiopathy—Capecitabine—prostate cancer	0.000192	0.00124	CcSEcCtD
Terlipressin—Bradycardia—Prednisone—prostate cancer	0.000192	0.00124	CcSEcCtD
Terlipressin—Vomiting—Conjugated Estrogens—prostate cancer	0.000192	0.00124	CcSEcCtD
Terlipressin—Abdominal pain—Estradiol—prostate cancer	0.000191	0.00123	CcSEcCtD
Terlipressin—Headache—Goserelin—prostate cancer	0.000191	0.00123	CcSEcCtD
Terlipressin—Malnutrition—Docetaxel—prostate cancer	0.00019	0.00123	CcSEcCtD
Terlipressin—Headache—Conjugated Estrogens—prostate cancer	0.000189	0.00122	CcSEcCtD
Terlipressin—Malnutrition—Capecitabine—prostate cancer	0.000184	0.00119	CcSEcCtD
Terlipressin—Tachycardia—Etoposide—prostate cancer	0.000183	0.00118	CcSEcCtD
Terlipressin—Skin disorder—Etoposide—prostate cancer	0.000182	0.00117	CcSEcCtD
Terlipressin—Nausea—Goserelin—prostate cancer	0.000181	0.00117	CcSEcCtD
Terlipressin—Nausea—Conjugated Estrogens—prostate cancer	0.000179	0.00116	CcSEcCtD
Terlipressin—Abdominal pain—Mitoxantrone—prostate cancer	0.000178	0.00115	CcSEcCtD
Terlipressin—Angiopathy—Prednisone—prostate cancer	0.000171	0.0011	CcSEcCtD
Terlipressin—Dyspnoea—Etoposide—prostate cancer	0.000167	0.00108	CcSEcCtD
Terlipressin—Diarrhoea—Estradiol—prostate cancer	0.000165	0.00107	CcSEcCtD
Terlipressin—Hypertension—Docetaxel—prostate cancer	0.000164	0.00106	CcSEcCtD
Terlipressin—Malnutrition—Prednisone—prostate cancer	0.000164	0.00106	CcSEcCtD
Terlipressin—Chest pain—Docetaxel—prostate cancer	0.000162	0.00105	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Etoposide—prostate cancer	0.000161	0.00104	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000161	0.00104	CcSEcCtD
Terlipressin—Hypertension—Capecitabine—prostate cancer	0.000159	0.00103	CcSEcCtD
Terlipressin—Chest pain—Capecitabine—prostate cancer	0.000157	0.00101	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000156	0.00101	CcSEcCtD
Terlipressin—Diarrhoea—Mitoxantrone—prostate cancer	0.000154	0.000993	CcSEcCtD
Terlipressin—Vomiting—Estradiol—prostate cancer	0.000153	0.00099	CcSEcCtD
Terlipressin—Nervous system disorder—Docetaxel—prostate cancer	0.000152	0.000984	CcSEcCtD
Terlipressin—Tachycardia—Docetaxel—prostate cancer	0.000152	0.000979	CcSEcCtD
Terlipressin—Headache—Estradiol—prostate cancer	0.000151	0.000976	CcSEcCtD
Terlipressin—Skin disorder—Docetaxel—prostate cancer	0.000151	0.000974	CcSEcCtD
Terlipressin—Bradycardia—Epirubicin—prostate cancer	0.00015	0.00097	CcSEcCtD
Terlipressin—Abdominal pain—Etoposide—prostate cancer	0.000148	0.000954	CcSEcCtD
Terlipressin—Nervous system disorder—Capecitabine—prostate cancer	0.000148	0.000952	CcSEcCtD
Terlipressin—Tachycardia—Capecitabine—prostate cancer	0.000147	0.000948	CcSEcCtD
Terlipressin—Skin disorder—Capecitabine—prostate cancer	0.000146	0.000943	CcSEcCtD
Terlipressin—Nausea—Estradiol—prostate cancer	0.000143	0.000925	CcSEcCtD
Terlipressin—Vomiting—Mitoxantrone—prostate cancer	0.000143	0.000923	CcSEcCtD
Terlipressin—Hypertension—Prednisone—prostate cancer	0.000142	0.000915	CcSEcCtD
Terlipressin—Headache—Mitoxantrone—prostate cancer	0.000141	0.000909	CcSEcCtD
Terlipressin—Bradycardia—Doxorubicin—prostate cancer	0.000139	0.000897	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000139	0.000896	CcSEcCtD
Terlipressin—Dyspnoea—Docetaxel—prostate cancer	0.000139	0.000894	CcSEcCtD
Terlipressin—Cardiac disorder—Epirubicin—prostate cancer	0.000137	0.000884	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000134	0.000866	CcSEcCtD
Terlipressin—Dyspnoea—Capecitabine—prostate cancer	0.000134	0.000866	CcSEcCtD
Terlipressin—Angiopathy—Epirubicin—prostate cancer	0.000134	0.000864	CcSEcCtD
Terlipressin—Nausea—Mitoxantrone—prostate cancer	0.000134	0.000862	CcSEcCtD
Terlipressin—Nervous system disorder—Prednisone—prostate cancer	0.000131	0.000848	CcSEcCtD
Terlipressin—Tachycardia—Prednisone—prostate cancer	0.000131	0.000844	CcSEcCtD
Terlipressin—Skin disorder—Prednisone—prostate cancer	0.00013	0.00084	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00013	0.000838	CcSEcCtD
Terlipressin—Malnutrition—Epirubicin—prostate cancer	0.000128	0.000829	CcSEcCtD
Terlipressin—Diarrhoea—Etoposide—prostate cancer	0.000128	0.000826	CcSEcCtD
Terlipressin—Cardiac disorder—Doxorubicin—prostate cancer	0.000127	0.000818	CcSEcCtD
Terlipressin—Angiopathy—Doxorubicin—prostate cancer	0.000124	0.000799	CcSEcCtD
Terlipressin—Abdominal pain—Docetaxel—prostate cancer	0.000123	0.000793	CcSEcCtD
Terlipressin—Abdominal pain—Capecitabine—prostate cancer	0.000119	0.000768	CcSEcCtD
Terlipressin—Vomiting—Etoposide—prostate cancer	0.000119	0.000767	CcSEcCtD
Terlipressin—Malnutrition—Doxorubicin—prostate cancer	0.000119	0.000767	CcSEcCtD
Terlipressin—Headache—Etoposide—prostate cancer	0.000117	0.000756	CcSEcCtD
Terlipressin—Desmopressin—PTGS2—prostate cancer	0.000113	0.252	CrCbGaD
Terlipressin—Nausea—Etoposide—prostate cancer	0.000111	0.000717	CcSEcCtD
Terlipressin—Hypertension—Epirubicin—prostate cancer	0.000111	0.000716	CcSEcCtD
Terlipressin—Chest pain—Epirubicin—prostate cancer	0.000109	0.000706	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000109	0.000701	CcSEcCtD
Terlipressin—Diarrhoea—Docetaxel—prostate cancer	0.000106	0.000686	CcSEcCtD
Terlipressin—Abdominal pain—Prednisone—prostate cancer	0.000106	0.000684	CcSEcCtD
Terlipressin—Diarrhoea—Capecitabine—prostate cancer	0.000103	0.000665	CcSEcCtD
Terlipressin—Nervous system disorder—Epirubicin—prostate cancer	0.000103	0.000664	CcSEcCtD
Terlipressin—Hypertension—Doxorubicin—prostate cancer	0.000103	0.000662	CcSEcCtD
Terlipressin—Tachycardia—Epirubicin—prostate cancer	0.000102	0.00066	CcSEcCtD
Terlipressin—Skin disorder—Epirubicin—prostate cancer	0.000102	0.000657	CcSEcCtD
Terlipressin—Chest pain—Doxorubicin—prostate cancer	0.000101	0.000653	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000101	0.000649	CcSEcCtD
Terlipressin—Vomiting—Docetaxel—prostate cancer	9.88e-05	0.000638	CcSEcCtD
Terlipressin—Headache—Docetaxel—prostate cancer	9.74e-05	0.000628	CcSEcCtD
Terlipressin—Vomiting—Capecitabine—prostate cancer	9.57e-05	0.000618	CcSEcCtD
Terlipressin—Nervous system disorder—Doxorubicin—prostate cancer	9.51e-05	0.000614	CcSEcCtD
Terlipressin—Tachycardia—Doxorubicin—prostate cancer	9.47e-05	0.000611	CcSEcCtD
Terlipressin—Headache—Capecitabine—prostate cancer	9.43e-05	0.000608	CcSEcCtD
Terlipressin—Skin disorder—Doxorubicin—prostate cancer	9.42e-05	0.000608	CcSEcCtD
Terlipressin—Dyspnoea—Epirubicin—prostate cancer	9.35e-05	0.000603	CcSEcCtD
Terlipressin—Nausea—Docetaxel—prostate cancer	9.23e-05	0.000596	CcSEcCtD
Terlipressin—Diarrhoea—Prednisone—prostate cancer	9.17e-05	0.000592	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Epirubicin—prostate cancer	9.05e-05	0.000584	CcSEcCtD
Terlipressin—Nausea—Capecitabine—prostate cancer	8.94e-05	0.000577	CcSEcCtD
Terlipressin—Dyspnoea—Doxorubicin—prostate cancer	8.65e-05	0.000558	CcSEcCtD
Terlipressin—Vomiting—Prednisone—prostate cancer	8.52e-05	0.00055	CcSEcCtD
Terlipressin—Headache—Prednisone—prostate cancer	8.4e-05	0.000542	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Doxorubicin—prostate cancer	8.38e-05	0.00054	CcSEcCtD
Terlipressin—Abdominal pain—Epirubicin—prostate cancer	8.29e-05	0.000535	CcSEcCtD
Terlipressin—Nausea—Prednisone—prostate cancer	7.96e-05	0.000514	CcSEcCtD
Terlipressin—Abdominal pain—Doxorubicin—prostate cancer	7.67e-05	0.000495	CcSEcCtD
Terlipressin—Diarrhoea—Epirubicin—prostate cancer	7.17e-05	0.000463	CcSEcCtD
Terlipressin—Vomiting—Epirubicin—prostate cancer	6.67e-05	0.00043	CcSEcCtD
Terlipressin—Diarrhoea—Doxorubicin—prostate cancer	6.64e-05	0.000428	CcSEcCtD
Terlipressin—Headache—Epirubicin—prostate cancer	6.57e-05	0.000424	CcSEcCtD
Terlipressin—Nausea—Epirubicin—prostate cancer	6.23e-05	0.000402	CcSEcCtD
Terlipressin—Vomiting—Doxorubicin—prostate cancer	6.17e-05	0.000398	CcSEcCtD
Terlipressin—Headache—Doxorubicin—prostate cancer	6.08e-05	0.000392	CcSEcCtD
Terlipressin—Nausea—Doxorubicin—prostate cancer	5.76e-05	0.000372	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—ITPR1—prostate cancer	4.66e-05	0.000415	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTHLH—prostate cancer	4.63e-05	0.000413	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFBR1—prostate cancer	4.63e-05	0.000413	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CB—prostate cancer	4.62e-05	0.000411	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFBR1—prostate cancer	4.6e-05	0.00041	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTHLH—prostate cancer	4.6e-05	0.00041	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKR1C3—prostate cancer	4.55e-05	0.000406	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRKACB—prostate cancer	4.53e-05	0.000404	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKR1C3—prostate cancer	4.52e-05	0.000403	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRKACB—prostate cancer	4.5e-05	0.000401	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1R—prostate cancer	4.46e-05	0.000397	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCL8—prostate cancer	4.44e-05	0.000395	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—THBS1—prostate cancer	4.42e-05	0.000394	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PPP3CA—prostate cancer	4.42e-05	0.000394	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—JAK2—prostate cancer	4.41e-05	0.000393	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—THBS1—prostate cancer	4.38e-05	0.000391	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PPP3CA—prostate cancer	4.38e-05	0.000391	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ANXA1—prostate cancer	4.35e-05	0.000388	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ANXA1—prostate cancer	4.32e-05	0.000385	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRKCZ—prostate cancer	4.27e-05	0.000381	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—LPL—prostate cancer	4.27e-05	0.000381	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRKCZ—prostate cancer	4.24e-05	0.000378	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2—prostate cancer	4.24e-05	0.000378	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PDGFRB—prostate cancer	4.23e-05	0.000377	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CB—prostate cancer	4.19e-05	0.000374	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CG—prostate cancer	4.18e-05	0.000372	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CG—prostate cancer	4.15e-05	0.000369	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGFR4—prostate cancer	4.13e-05	0.000368	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PARP1—prostate cancer	4.13e-05	0.000368	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ITGB3—prostate cancer	4.13e-05	0.000368	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGFR4—prostate cancer	4.1e-05	0.000365	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PARP1—prostate cancer	4.1e-05	0.000365	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CALCA—prostate cancer	4.08e-05	0.000363	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CALCA—prostate cancer	4.05e-05	0.000361	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL8—prostate cancer	4.03e-05	0.000359	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB3—prostate cancer	4e-05	0.000357	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FGFR2—prostate cancer	4e-05	0.000356	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL12—prostate cancer	3.98e-05	0.000355	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL12—prostate cancer	3.95e-05	0.000352	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2—prostate cancer	3.85e-05	0.000343	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TERT—prostate cancer	3.84e-05	0.000342	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CG—prostate cancer	3.79e-05	0.000338	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CG—prostate cancer	3.76e-05	0.000335	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP9—prostate cancer	3.75e-05	0.000334	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP9—prostate cancer	3.72e-05	0.000332	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CD—prostate cancer	3.67e-05	0.000327	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HIF1A—prostate cancer	3.67e-05	0.000327	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CD—prostate cancer	3.64e-05	0.000325	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRKCQ—prostate cancer	3.63e-05	0.000324	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NGFR—prostate cancer	3.63e-05	0.000324	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NGFR—prostate cancer	3.61e-05	0.000321	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRKCQ—prostate cancer	3.61e-05	0.000321	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAP3K7—prostate cancer	3.59e-05	0.00032	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—LEP—prostate cancer	3.58e-05	0.000319	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAP3K7—prostate cancer	3.56e-05	0.000318	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CAV1—prostate cancer	3.55e-05	0.000316	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KDR—prostate cancer	3.51e-05	0.000313	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGF10—prostate cancer	3.45e-05	0.000308	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGF10—prostate cancer	3.43e-05	0.000305	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ESR1—prostate cancer	3.42e-05	0.000305	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ADRB2—prostate cancer	3.41e-05	0.000304	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ADRB2—prostate cancer	3.39e-05	0.000302	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—JAK2—prostate cancer	3.37e-05	0.0003	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAP2K1—prostate cancer	3.36e-05	0.000299	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—JAK2—prostate cancer	3.34e-05	0.000298	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BAD—prostate cancer	3.34e-05	0.000297	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CD—prostate cancer	3.33e-05	0.000297	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAP2K1—prostate cancer	3.33e-05	0.000297	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VAV3—prostate cancer	3.33e-05	0.000297	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CD—prostate cancer	3.31e-05	0.000295	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VAV3—prostate cancer	3.31e-05	0.000295	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFBR2—prostate cancer	3.28e-05	0.000293	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFBR2—prostate cancer	3.26e-05	0.00029	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APC—prostate cancer	3.23e-05	0.000288	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CG—prostate cancer	3.23e-05	0.000288	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ITPR1—prostate cancer	3.23e-05	0.000288	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ITPR1—prostate cancer	3.21e-05	0.000286	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CB—prostate cancer	3.2e-05	0.000285	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGF—prostate cancer	3.19e-05	0.000285	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IRS1—prostate cancer	3.19e-05	0.000285	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CB—prostate cancer	3.18e-05	0.000283	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GSK3B—prostate cancer	3.1e-05	0.000276	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1R—prostate cancer	3.09e-05	0.000275	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL8—prostate cancer	3.07e-05	0.000274	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1R—prostate cancer	3.07e-05	0.000273	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—JAK2—prostate cancer	3.06e-05	0.000273	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—INS—prostate cancer	3.06e-05	0.000273	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL8—prostate cancer	3.05e-05	0.000272	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—JAK2—prostate cancer	3.04e-05	0.000271	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CREBBP—prostate cancer	3e-05	0.000267	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LPL—prostate cancer	2.96e-05	0.000264	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1—prostate cancer	2.96e-05	0.000264	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EGFR—prostate cancer	2.94e-05	0.000262	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LPL—prostate cancer	2.94e-05	0.000262	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—prostate cancer	2.94e-05	0.000262	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PDGFRB—prostate cancer	2.93e-05	0.000262	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—prostate cancer	2.92e-05	0.00026	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PDGFRB—prostate cancer	2.91e-05	0.00026	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CB—prostate cancer	2.91e-05	0.000259	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CB—prostate cancer	2.88e-05	0.000257	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ITGB3—prostate cancer	2.86e-05	0.000255	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAP2K1—prostate cancer	2.86e-05	0.000255	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CD—prostate cancer	2.84e-05	0.000253	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ITGB3—prostate cancer	2.84e-05	0.000253	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CA—prostate cancer	2.81e-05	0.000251	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SERPINE1—prostate cancer	2.81e-05	0.00025	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL8—prostate cancer	2.79e-05	0.000249	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—KRAS—prostate cancer	2.78e-05	0.000248	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB3—prostate cancer	2.77e-05	0.000247	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL8—prostate cancer	2.77e-05	0.000247	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGFR2—prostate cancer	2.77e-05	0.000247	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB3—prostate cancer	2.75e-05	0.000245	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGFR2—prostate cancer	2.75e-05	0.000245	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FGF2—prostate cancer	2.72e-05	0.000242	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOS3—prostate cancer	2.68e-05	0.000239	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—prostate cancer	2.67e-05	0.000238	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TERT—prostate cancer	2.66e-05	0.000237	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—prostate cancer	2.65e-05	0.000236	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TERT—prostate cancer	2.64e-05	0.000235	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—JAK2—prostate cancer	2.61e-05	0.000232	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CA—prostate cancer	2.56e-05	0.000228	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MDM2—prostate cancer	2.54e-05	0.000227	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HIF1A—prostate cancer	2.54e-05	0.000227	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HIF1A—prostate cancer	2.52e-05	0.000225	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB2—prostate cancer	2.51e-05	0.000224	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LEP—prostate cancer	2.48e-05	0.000221	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CB—prostate cancer	2.48e-05	0.000221	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LEP—prostate cancer	2.46e-05	0.00022	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CAV1—prostate cancer	2.46e-05	0.000219	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CAV1—prostate cancer	2.44e-05	0.000218	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KDR—prostate cancer	2.43e-05	0.000217	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KDR—prostate cancer	2.41e-05	0.000215	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL8—prostate cancer	2.38e-05	0.000212	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ESR1—prostate cancer	2.37e-05	0.000211	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ESR1—prostate cancer	2.35e-05	0.00021	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1B—prostate cancer	2.32e-05	0.000207	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BAD—prostate cancer	2.31e-05	0.000206	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—prostate cancer	2.3e-05	0.000205	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BAD—prostate cancer	2.3e-05	0.000205	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—prostate cancer	2.28e-05	0.000203	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—prostate cancer	2.27e-05	0.000203	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—prostate cancer	2.26e-05	0.000202	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APC—prostate cancer	2.24e-05	0.0002	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CG—prostate cancer	2.24e-05	0.0002	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CG—prostate cancer	2.22e-05	0.000198	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APC—prostate cancer	2.22e-05	0.000198	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCND1—prostate cancer	2.22e-05	0.000198	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IRS1—prostate cancer	2.21e-05	0.000197	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGF—prostate cancer	2.21e-05	0.000197	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGF—prostate cancer	2.2e-05	0.000196	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IRS1—prostate cancer	2.2e-05	0.000196	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CTNNB1—prostate cancer	2.2e-05	0.000196	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—prostate cancer	2.15e-05	0.000192	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GSK3B—prostate cancer	2.15e-05	0.000192	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1A—prostate cancer	2.14e-05	0.000191	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTEN—prostate cancer	2.14e-05	0.000191	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GSK3B—prostate cancer	2.13e-05	0.00019	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—INS—prostate cancer	2.12e-05	0.000189	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—INS—prostate cancer	2.1e-05	0.000188	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—prostate cancer	2.09e-05	0.000186	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CREBBP—prostate cancer	2.08e-05	0.000185	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CREBBP—prostate cancer	2.06e-05	0.000184	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1—prostate cancer	2.05e-05	0.000183	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EGFR—prostate cancer	2.04e-05	0.000182	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EP300—prostate cancer	2.04e-05	0.000182	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1—prostate cancer	2.04e-05	0.000181	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EGFR—prostate cancer	2.03e-05	0.000181	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SRC—prostate cancer	1.98e-05	0.000177	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAP2K1—prostate cancer	1.98e-05	0.000177	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CD—prostate cancer	1.97e-05	0.000175	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAP2K1—prostate cancer	1.97e-05	0.000175	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CD—prostate cancer	1.95e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CA—prostate cancer	1.95e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SERPINE1—prostate cancer	1.95e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CA—prostate cancer	1.94e-05	0.000173	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SERPINE1—prostate cancer	1.93e-05	0.000172	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—prostate cancer	1.93e-05	0.000172	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—KRAS—prostate cancer	1.93e-05	0.000172	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KRAS—prostate cancer	1.91e-05	0.000171	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—prostate cancer	1.91e-05	0.000171	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGF2—prostate cancer	1.89e-05	0.000168	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGF2—prostate cancer	1.87e-05	0.000167	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOS3—prostate cancer	1.86e-05	0.000166	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOS3—prostate cancer	1.85e-05	0.000165	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JAK2—prostate cancer	1.81e-05	0.000161	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JAK2—prostate cancer	1.79e-05	0.00016	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—prostate cancer	1.78e-05	0.000158	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFB1—prostate cancer	1.77e-05	0.000158	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CA—prostate cancer	1.77e-05	0.000158	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MDM2—prostate cancer	1.76e-05	0.000157	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CA—prostate cancer	1.76e-05	0.000157	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MDM2—prostate cancer	1.75e-05	0.000156	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB2—prostate cancer	1.74e-05	0.000155	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGFR—prostate cancer	1.74e-05	0.000155	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB2—prostate cancer	1.73e-05	0.000154	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CB—prostate cancer	1.72e-05	0.000153	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CB—prostate cancer	1.7e-05	0.000152	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL8—prostate cancer	1.65e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KRAS—prostate cancer	1.64e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL8—prostate cancer	1.64e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1B—prostate cancer	1.61e-05	0.000144	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1B—prostate cancer	1.6e-05	0.000143	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—prostate cancer	1.59e-05	0.000142	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—prostate cancer	1.58e-05	0.000141	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—prostate cancer	1.58e-05	0.000141	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—prostate cancer	1.58e-05	0.00014	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—prostate cancer	1.57e-05	0.00014	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—prostate cancer	1.57e-05	0.00014	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—prostate cancer	1.56e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—prostate cancer	1.56e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCND1—prostate cancer	1.54e-05	0.000137	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCND1—prostate cancer	1.53e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CTNNB1—prostate cancer	1.52e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CTNNB1—prostate cancer	1.51e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CA—prostate cancer	1.51e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—prostate cancer	1.49e-05	0.000133	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1A—prostate cancer	1.49e-05	0.000132	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTEN—prostate cancer	1.48e-05	0.000132	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—prostate cancer	1.48e-05	0.000132	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1A—prostate cancer	1.48e-05	0.000132	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTEN—prostate cancer	1.47e-05	0.000131	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—prostate cancer	1.46e-05	0.00013	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—prostate cancer	1.45e-05	0.000129	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—prostate cancer	1.44e-05	0.000128	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EP300—prostate cancer	1.41e-05	0.000126	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EP300—prostate cancer	1.4e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SRC—prostate cancer	1.38e-05	0.000123	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SRC—prostate cancer	1.37e-05	0.000122	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—prostate cancer	1.34e-05	0.000119	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—prostate cancer	1.34e-05	0.000119	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—prostate cancer	1.33e-05	0.000119	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—prostate cancer	1.33e-05	0.000118	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—prostate cancer	1.32e-05	0.000117	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—prostate cancer	1.23e-05	0.00011	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—prostate cancer	1.23e-05	0.00011	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFB1—prostate cancer	1.23e-05	0.00011	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—prostate cancer	1.22e-05	0.000109	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFB1—prostate cancer	1.22e-05	0.000109	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGFR—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGFR—prostate cancer	1.2e-05	0.000107	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KRAS—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KRAS—prostate cancer	1.13e-05	0.000101	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CA—prostate cancer	1.05e-05	9.32e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CA—prostate cancer	1.04e-05	9.26e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—prostate cancer	1.01e-05	9.02e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—prostate cancer	1e-05	8.96e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—prostate cancer	9.26e-06	8.26e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—prostate cancer	9.2e-06	8.2e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—prostate cancer	8.55e-06	7.62e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—prostate cancer	8.49e-06	7.56e-05	CbGpPWpGaD
